Society of Breast Imaging Cancels 2020 Conference
The Society of Breast Imaging (SBI) announced it has canceled its annual symposium with the American College of Radiology due to concerns over the growing COVID-19 outbreak. The meeting had been planned for April 16-19 in Denver.
"Protecting the health and well-being of all attendees is our greatest concern," said SBI President Margarita L. Zuley, M.D., in a written statement. "Canceling the Symposium required much discussion and deep consideration. It was a decision we came to reluctantly."
The organization made its decision after reviewing the World Health Organization's evaluations, as well as the ongoing amount of research being published on the impact of the virus. Full refunds will be made available to all registered attendees over the next few weeks, according to the press announcement.
There are no plans to reschedule the meeting for later this year. Instead, the next meeting is planned for April 8-11, 2021, in Savannah, Ga.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
What a New Study Reveals About Adjunctive DBT and Early-Stage Invasive Breast Cancer
December 6th 2023The combination of digital breast tomosynthesis (DBT) and digital mammography had a 21.6 higher invasive breast cancer detection rate for stage 1 tumors than digital mammography alone, according to a new study involving nearly 100,000 women.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.
Study Says Contrast-Enhanced Mammography Offers Comparable Breast Cancer Detection to MRI
November 15th 2023In findings from an enriched cohort of asymptomatic patients with screening-detected abnormalities, researchers found that contrast-enhanced mammography (CEM) was superior to conventional mammography and offered equivalent detection of breast cancer in comparison to breast MRI and abbreviated breast MRI.
